Epigenesis Pharmaceuticals LLC develops inhaled respiratory medicines. It also provides treatments for the asthma, obstructive pulmonary disease and other respiratory diseases. The company was founded by Jonathan W. Nyce in 1995 and is headquartered in Cranbury, NJ.

As of January 6, 2009, Genelabs Technologies Inc. was acquired by SmithKline Beecham Corporation. Genelabs Technologies, Inc., a biopharmaceutical company, engages in the discovery and development of infectious disease therapies to improve human health. The company's product pipeline consists of infectious disease projects focusing on Hepatitis C virus infection; and late-stage clinical assets, including an investigational vaccine for hepatitis E virus that is being developed by GlaxoSmithKline; and Prestara, an investigational drug for systemic lupus erythematosus. It has license and collaboration agreement with the Novartis Institutes for BioMedical Research for HCV polymerase non-nucleoside discovery research. Genelabs Technologies also has a collaborative research agreement with the National Health Research Institutes and Genovate Biotechnology Co., Ltd. to discover and develop compounds that target the hepatitis C virus. The company was founded in 1983 and is headquartered in Redwood City, California.

Medy-Tox, Inc. engages in the manufacture and sale of biopharmaceutical products. Its products include botulinum toxin, hyaluronic acid filler, medical devices, toxin detection kit and antitoxin therapeutics. The company was founded on May 2, 2000 and is headquartered in Cheongwon-gun, South Korea.

Pantarhei Bioscience BV (PRB) is a limited liability company (Besloten Vennootschap) located in the Netherlands focussing on the development of innovative concepts for woman’s health and hormone-related cancer treatments. PRB has founded a subsidiary company – Pantarhei Oncology (PRO) – to develop treatments for Endocrine Cancer. PRB has developed a product pipeline based on its ability to identify novel medical uses of existing molecules, drugs, hormones, biologicals and combinations thereof in these areas of medicine. The main areas of expertise of PRB are reproductive hormone related treatments and diseases such as contraception and menopausal hormone therapy (MHT). The main areas of expertise of PRO are breast cancer, prostate cancer and ovarian cancer . PRB develops patent protected new treatment concepts up to proof-of-concept (PoC) in the human (phase II). Using existing molecules often provides first evidence of safety. The business model of the Pantarhei companies is based on creating intellectual property (IP) of new concepts ad inventions, in-house project management and outsourcing of all research and development activities. After successful PoC, data and IP are licensed out to a licensee or partner for completion of clinical development (phase III), regulatory approval and sales and marketing by a licensee/partner.

Beijing Huarui Dingxin Technology Co., Ltd., established on 1999-01-27, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Socioeconomic Advisory Services;Labor service(Does not include labor dispatch).(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:Pharmaceutical commissioned production;Inspection and testing service.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)(Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Laboratorios Andrómaco SA is a pharmaceutical company. It is engaged in the production and marketing of pharmaceutical products and diagnostics. The company was founded in 1942 and is headquartered in Peñalolén, Chile.

Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. It operates through the following segments: Global Generics, Pharmaceutical Services & Active Ingredients, Proprietary Products, and Others. The Global Generics segment consists of manufacturing and marketing of prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name or as generic finished dosages with therapeutic equivalence to branded formulations. The Pharmaceutical Services & Active Ingredients segment is comprised of manufacturing and marketing of active pharmaceutical ingredients and intermediates, also known as API, which are the principal ingredients for finished pharmaceutical products. The Proprietary Products segment focuses on research and development of differentiated formulations. The Others segment includes the operations of the subsidiary of the company. The company was founded by Kallam Anji Reddy on February 24, 1984 and is headquartered in Hyderabad, India.

CUSTOMIZED TREATMENT PROGRAMS. BIO-IDENTICAL HORMONES IN AN ORGANIC BASE.

Inflabloc Pharmaceuticals, Inc. engages in the research and development of pharmaceutical treatments. It develops products for the treatment of gastrointestinal disorders and inflammatory diseases. The company was founded in 1991 and is headquartered in Salt Lake City, UT.

Intervene Immune offer innovative treatments for the regeneration of the thymus and the aging of the immune system at Intervene Immune. They treat foreign invaders by educating bone marrow-derived cells to become the T cells that carry out cellular immune functions and protect from foreign invaders such as bacteria and viruses.

Produces and distributes cosmetics, toiletries, textiles and food products

Sterix Ltd. provides pharmaceutical research services for oncology and endocrine related diseases. It develops artificial steroid hormones and other drug preparations. The company was founded in 1998 and is headquartered in Oxford, UK.

Guangzhou Meilaijie Cosmetics Development Co., Ltd., established on 2020-08-28, Business scope includes biotechnology development services;Biotechnology Consulting,communication service;New material technology promotion service;Manufacturing of Oral Cleaning Products;Wholesale of cosmetics and hygiene products;Cosmetics Wholesale;Cosmetic technology development;Cosmetic Manufacturing;Chemical Engineering Research Services;Chemical product testing service;Biotechnology Extension Services;Energy-saving technology promotion service;Environmental protection technology promotion service;Manufacturing of special chemicals(Monitor Chemicals,Excluding hazardous chemicals);Chemical Reagent and Auxiliary Manufacturing(Monitor Chemicals,Excluding hazardous chemicals);Manufacturing of organic chemical raw materials(Monitor Chemicals,Excluding hazardous chemicals);Operation of non-licensed medical devices;Technology Import and Export;Food Science and Technology Research Services;;

Fujian Wushan Fengding Tea Co., Ltd., established on 2014-10-14, Business scope includes general items:tea planting;Primary processing of edible agricultural products;Tea set sales;food business(Selling prepackaged food);Food Internet Sales(Selling prepackaged food)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license) licensed items:Production of tea products;food production;food business;food paper packaging,Production of container products;Food Internet Sales;Food import and export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments) (not in<Negative List for Foreign Investment Access>Business activities in areas where foreign investment is prohibited)

Schering AG was a research-centered German multinational pharmaceutical company headquartered in Wedding, Berlin, which operated as an independent company from 1851 to 2006. In 2006 it was bought by Bayer AG and merged to form the Bayer subsidiary Bayer Schering Pharma AG, which was renamed Bayer HealthCare Pharmaceuticals in 2011. Schering was listed on the Frankfurt Stock Exchange and had 26,000 employees as of 2004.

Hangzhou Baichen Medical Laboratory Co., Ltd., established on 2016-07-13, Business scope includes licensed projects:medical service;Inspection and testing service;Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;Class III Medical Device Leasing(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).General project:Production of Class I Medical Devices;Sales of Class II Medical Devices;Class II Medical Device Leasing;Sales of Class I Medical Devices;Class I Medical Device Leasing;Medical Research and Experimental Development;Manufacturing of experimental analysis instruments;Experimental analysis instrument sales;Instrument Manufacturing;Instrument sales;Manufacturing of Specialty Chemical Products(Free of Hazardous Chemicals);Specialty Chemicals Sales(Free of Hazardous Chemicals);Communication equipment manufacturing;Communication equipment sales;software sales;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Information Technology Consulting Services;Clinic Services;Import and export(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Wuhan Linbaolai Biotechnology Co., Ltd., established on 2018-07-16, Business scope includes general items:Research and development of bio-based materials technology;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Sales of bio-based materials;General merchandise sales;Cosmetics Retail;Sales of power facilities and equipment;Sales of clothing accessories;Auto Parts Wholesale;Home Appliance Sales;Business Management Consulting(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:Import and export;Technology Import and Export;food business(Selling prepackaged food);food business(sell bulk food)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Harbin Lingchun Taste Food Development Co., Ltd., established on 2013-10-22, Business scope includes general items:Engineering and Technology Research and Experimental Development;Catering Management;brand management;Business Management Consulting;marketing planning;advertisement making;Advertising Design,acting;advertising;food sales(Only sell prepackaged food);Retail of kitchenware, sanitary ware and daily necessities;General merchandise sales;Food detergent sales;Business agency service;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;housing lease;software sales;software development;Etiquette service;business training(Does not include education and training,Vocational skills training and other licensed training).licensed items:food production;food sales.